New transparency rule requiring hospitals to post prices confuses patients

A new federal policy took effect on Jan. 1 that requires hospitals to post standard prices online. However, the rule, which intends to boost transparency, may be causing more confusion than clarity for patients, according to reports.

The rule, which was introduced in April 2018 and was met with support from hospital industry groups, isn’t making navigating the healthcare space any easier for patients. Met with an indiscernible order of medical codes, abbreviations and dollar signs, consumers aren’t able to figure out how much a procedure will cost beforehand by looking at the online information, CNN reported.

To figure out the cost of a hospital visit, consumers have to locate and add up each price component from the online information, called the Chargemaster––a challenging feat, according to CNN. In addition, those prices might not reflect actual amounts charged to different insurers, further confusing how much consumers would have to pay.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.